reliable and effective growth for regenerative health options that improve wellness or the regrow act - amends the federal food, drug, and cosmetic act to direct the secretary of health and human services (hhs) to establish a program to conditionally approve a cellular therapeutic product if the sponsor of such product demonstrates preliminary clinical evidence of law, and a reasonable expectation of [UNK] without initiation of phase iii [UNK] a conditionally approved product shall: (1) establish a program to conditionally approve a cellular therapeutic product if the sponsor of such product demonstrates preliminary clinical evidence of law, and a reasonable